Anne Louise Nielsen

Self-assembling microparticles with controllable disruption properties based on cyclodextrin interactions.

In this paper, we present the formation of particles by self-assembly of cyclodextrin polymers and hydrophobically modified dextran followed by a controlled disruption of the particles by addition of a trigger molecule competing for the cyclodextrin cavities. The produced particles are formed from poly(vinylpyrrolidone)-co-beta-cyclodextrin and dextran-benzoate, both biocompatible polymers, and are all in the nano-/micrometer range and hence suitable for drug delivery purposes. The particle formation was studied in different ratios of poly(vinylpyrrolidone)-co-beta-cyclodextrin and dextran-benzoate by visual inspections, dynamic light scattering, isothermal titration calorimetry and SEM. The triggering of particle disruption was achieved by addition of hydroxyadamantane which has a very strong affinity towards the beta-cyclodextrin cavities. The stepwise addition of hydroxyadamantane was followed by dynamic light scattering and SEM measurements, revealing a disruption of the particles due to the addition of this competitor. These particles are believed to be promising candidates for controlled drug delivery systems, due to their unique ability to disrupt in a controlled manner.

Cyclodextrin modified hydrogels of PVP/PEG for sustained drug release

Hydrogels are water swollen networks of polymers and especially hydrogels consisting of poly vinylpyrrolidone/poly ethyleneglycol-dimethacrylate (PVP/PEG-DMA) blends show promising wound care properties. Enhanced functionality of the hydrogels can be achieved by incorporating drugs and other substances that may assist wound healing into the gel matrix. Controlling the release of active compounds from the hydrogels may be possible by carefully modifying the polymer matrix. For this purpose, cyclodextrins (CD) were grafted to the polymer matrix in 4–5 w/w% in an attempt to retard the release of water-soluble drugs. Ibuprofenate (IBU) was chosen as model drug and loaded in IBU/CD ratios of 0.6, 1.2, and 2.5. Vinyl derivatives of α-, β- and γ-CD were produced, added to the prepolymer blend and cured by UV-light. During this curing process the CD derivatives were covalently incorporated into the hydrogel matrix. The modified hydrogels were loaded with ibuprofenate by swelling. The release of the model drug from CD modified hydrogels show that especially covalently bonded β-cyclodextrin can change both the release rate and the release profile of ibuprofen.